China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Application of a PRO-Driven Symptom Management Question‑Answering System for Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132841

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Henan Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343984

Published by HT Digital Content Services with permission from Health Daily Digest....